YOUR BUSINESS AUTHORITY
Springfield, MO
Gilead Sciences Inc. has agreed to purchase German biotech firm Tubulis GmbH.
The deal is valued at up to $5 billion.
The agreement calls for $3.2 billion up front and more money if certain milestones are met.
Read more from Bloomberg.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects